102 related articles for article (PubMed ID: 15188132)
1. The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids.
Zhang PJ; Furth EE; Cai X; Goldblum JR; Pasha TL; Min KW
Hum Pathol; 2004 Jun; 35(6):670-4. PubMed ID: 15188132
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
Krishnamurthy S; Dayal Y
Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
[TBL] [Abstract][Full Text] [Related]
3. [Expression of transforming growth factor beta 1 (TGF beta 1) and angiogenesis in broncho-pulmonary carcinoids].
Słodkowska J; Hasleton P; Radomski P
Pneumonol Alergol Pol; 2000; 68(7-8):319-26. PubMed ID: 11200746
[TBL] [Abstract][Full Text] [Related]
4. Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps: an immunohistochemical study.
Zhang PJ; Weber R; Liang HH; Pasha TL; LiVolsi VA
Arch Pathol Lab Med; 2003 Nov; 127(11):1480-4. PubMed ID: 14567719
[TBL] [Abstract][Full Text] [Related]
5. Growth factors and carcinoid tumours.
Nilsson O; Wängberg B; McRae A; Dahlström A; Ahlman H
Acta Oncol; 1993; 32(2):115-24. PubMed ID: 8323752
[TBL] [Abstract][Full Text] [Related]
6. High expression of growth factors and growth factor receptors in ovarian metastases from ileal carcinoids: an immunohistochemical study of 2 cases.
Facco C; La Rosa S; Dionigi A; Uccella S; Riva C; Capella C
Arch Pathol Lab Med; 1998 Sep; 122(9):828-32. PubMed ID: 9740144
[TBL] [Abstract][Full Text] [Related]
7. Different beta-catenin immunoexpression in carcinoid tumors of the appendix in comparison to other gastrointestinal carcinoid tumors.
Barshack I; Goldberg I; Chowers Y; Horowitz A; Kopolovic J
Pathol Res Pract; 2002; 198(8):531-6. PubMed ID: 12389996
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoid of the small intestine. Mesenteric vascular lesions. Apropos of 3 cases].
Hemet J; Duval C; Jouanneau P; Geffroy Y; Colin R
Ann Anat Pathol (Paris); 1972; 17(1):73-82. PubMed ID: 5082966
[No Abstract] [Full Text] [Related]
9. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids.
Eckhauser FE; Argenta LC; Strodel WE; Wheeler RH; Bull FE; Appelman HD; Thompson NW
Surgery; 1981 Oct; 90(4):720-8. PubMed ID: 7281010
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors.
Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A
Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of beta-catenin, BMP4 and TGF-beta in odontomas.
de França GM; Pires HF; da Silva WR; de Morais ÉF; Freitas RA; de Souza LB; Galvão HC
Anat Histol Embryol; 2024 Mar; 53(2):e13024. PubMed ID: 38409855
[TBL] [Abstract][Full Text] [Related]
12. Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors.
Al-Khafaji B; Noffsinger AE; Miller MA; DeVoe G; Stemmermann GN; Fenoglio-Preiser C
Hum Pathol; 1998 Sep; 29(9):992-9. PubMed ID: 9744317
[TBL] [Abstract][Full Text] [Related]
13. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.
Chaudhry A; Papanicolaou V; Oberg K; Heldin CH; Funa K
Cancer Res; 1992 Feb; 52(4):1006-12. PubMed ID: 1310635
[TBL] [Abstract][Full Text] [Related]
14. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system.
Chaudhry A; Funa K; Oberg K
Acta Oncol; 1993; 32(2):107-14. PubMed ID: 8391829
[TBL] [Abstract][Full Text] [Related]
15. Ileal carcinoid tumors and intestinal ischemia.
Strobbe L; D'Hondt E; Ramboer C; Ceuppens H; Hinnekens P; Verhamme M
Hepatogastroenterology; 1994 Oct; 41(5):499-502. PubMed ID: 7851861
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
[TBL] [Abstract][Full Text] [Related]
17. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
[TBL] [Abstract][Full Text] [Related]
18. IMP3, NESP55, TTF-1 and CDX2 serve as an immunohistochemical panel in the distinction among small-cell carcinoma, gastrointestinal carcinoid, and pancreatic endocrine tumor metastasized to the liver.
Denby KS; Briones AJ; Bourne PA; Spaulding BO; Lu D; Fischer-Colbrie R; Qu Z; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):573-9. PubMed ID: 22495359
[TBL] [Abstract][Full Text] [Related]
19. An analysis of trends and growth factor receptor expression of GI carcinoid tumors.
Bowen KA; Silva SR; Johnson JN; Doan HQ; Jackson LN; Gulhati P; Qiu S; Riall TS; Evers BM
J Gastrointest Surg; 2009 Oct; 13(10):1773-80. PubMed ID: 19582519
[TBL] [Abstract][Full Text] [Related]
20. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study.
Jirásek T; Hozák P; Mandys V
Neoplasma; 2003; 50(1):1-7. PubMed ID: 12687271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
